All Stories

  1. Effect of CPAP Therapy in Poststroke Patients with Sleep-Disordered Breathing: A Systematic Review and Meta-Analysis
  2. Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study
  3. A review of sleep research in patients with spinal cord injury
  4. Sleep quality and circadian rhythm disruption in the intensive care unit: a review
  5. A Sleep Position Trainer for positional sleep apnea: a randomized, controlled trial
  6. Melatonin Secretion Pattern in Critically Ill Patients: A Pilot Descriptive Study
  7. Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
  8. Subjective sleep quality and daytime sleepiness in late midlife and their association with age-related changes in cognition
  9. Sleep stability and transitions in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease
  10. Melatonin and cortisol profiles in late midlife and their association with age-related changes in cognition
  11. Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset
  12. Inter-expert and intra-expert reliability in sleep spindle scoring
  13. A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
  14. Onset of impaired sleep as a predictor of change in health-related behaviours; analysing observational data as a series of non-randomized pseudo-trials
  15. Physical activity and the association with fatigue and sleep in Danish patients with rheumatoid arthritis
  16. HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
  17. Analysis of automated quantification of motor activity in REM sleep behaviour disorder
  18. Einfluss nächtlicher Hypoglykämien auf den Schlaf bei Menschen mit Typ 2 Diabetes
  19. All-cause mortality from obstructive sleep apnea in male and female patients with and without continuous positive airway pressure treatment: a registry study with 10 years of follow-up
  20. Blunted autonomic response in cluster headache patients
  21. The economic burden of Tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses
  22. EIF3G is associated with narcolepsy across ethnicities
  23. Heart rate response during sleep in elderly patients after fast-track hip and knee arthroplasty
  24. Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis
  25. The efficacy of motivational counseling and SMS-reminders on daily sitting time in patients with rheumatoid arthritis: protocol for a randomized controlled trial
  26. Automated differentiation between epileptic and nonepileptic convulsive seizures
  27. Sleep and chronobiology in cluster headache
  28. Automatic Real-Time Embedded QRS Complex Detection for a Novel Patch-Type Electrocardiogram Recorder
  29. HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
  30. Sleep in cluster headache − beyond a temporal rapid eye movement relationship?
  31. Erratum to: Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study
  32. Reduced CSF hypocretin-1 levels are associated with cluster headache
  33. Impaired sleep and allostatic load: cross-sectional results from the Danish Copenhagen Aging and Midlife Biobank
  34. miRNA profiles in cerebrospinal fluid from patients with central hypersomnias
  35. A Comprehensive Study of Extended Tetrathiafulvalene Cruciform Molecules for Molecular Electronics: Synthesis and Electrical Transport Measurements
  36. Health, Social and Economic Consequences of Polyneuropathy: A Controlled National Study Evaluating Societal Effects on Patients and Their Partners
  37. Increased all-cause mortality with psychotropic medication in Parkinson's disease and controls: A national register-based study
  38. Does autoreactivity have a role in narcolepsy?
  39. OP5 THE IMPACT OF NOCTURNAL HYPOGLYCAEMIA ON SLEEP IN SUBJECTS WITH TYPE 2 DIABETES
  40. Early Automatic Detection of Parkinsonʼs Disease Based on Sleep Recordings
  41. HLA DQB1*06:02 Negative Narcolepsy with Hypocretin/Orexin Deficiency
  42. Sleep–Wake Transition in Narcolepsy and Healthy Controls Using a Support Vector Machine
  43. EHMTI-0150. A controlled study of sleep in cluster headache patients.apo04
  44. EHMTI-0149. Low CSF hypocretin-1 levels are associated with cluster headache
  45. miRNA Profiles in Plasma from Patients with Sleep Disorders Reveal Dysregulation of miRNAs in Narcolepsy and Other Central Hypersomnias
  46. Automatic sleep classification using a data-driven topic model reveals latent sleep states
  47. Data-driven modeling of sleep EEG and EOG reveals characteristics indicative of pre-Parkinson's and Parkinson's disease
  48. Novel method for detection of Sleep Apnoea using respiration signals
  49. Detection of K-complexes based on the wavelet transform
  50. Automatic quality classification of entire electrocardiographic recordings obtained with a novel patch type recorder
  51. Sleep Problems and Daily Functioning in Children With ADHD: An Investigation of the Role of Impairment, ADHD Presentations, and Psychiatric Comorbidity
  52. Quantitative analysis of surface electromyography during epileptic and nonepileptic convulsive seizures
  53. P409: Automatic MSLT sleep/wake detection using novelty feature scaling
  54. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination
  55. P1045: Automatic sleep classification using a data-driven approach reveals six latent sleep states
  56. P201: Late midlife sleep pattern and sleep structure and the association to age-related changes in cognition
  57. P1056: Secondary narcolepsy with intermediate hypocretin level due to brain tumour – a case story
  58. P97: Frontal lobe epilepsy versus NREM sleep parasomnia: clinical and EEG characteristics
  59. P1046: Data-driven modeling of sleep EEG and EOG reveals stages indicative of pre-Parkinson and Parkinson’s disease
  60. P296: Sensorimotor gating deficits in multiple system atrophy: comparison with Parkinson’s disease and idiopathic REM sleep behavior disorder
  61. P482: Reliable monitoring of respiration rate with reflectance-mode photoplethysmography
  62. O36: Sleep spindle scoring: performance of humans versus machines
  63. P203: Subjective sleep quality and daytime sleepiness in late midlife and the association to age-related changes in cognition
  64. P295: Increased motor activity during REM sleep is linked with dopamine-function in idiopathic REM sleep behaviour disorder and Parkinson’s disease
  65. Sleep Impairment and Prognosis of Acute Myocardial Infarction: A Prospective Cohort Study
  66. The sensory construction of dreams and nightmare frequency in congenitally blind and late blind individuals
  67. Morbidity in early Parkinson's disease and prior to diagnosis
  68. Epidemiology of sleep apnea/hypopnea syndrome and sleep-disordered breathing
  69. Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study
  70. Sleep-wake and melatonin pattern in craniopharyngioma patients
  71. Postoperative Sleep Disturbances after Zolpidem Treatment in Fast-Track Hip and Knee Replacement
  72. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease
  73. Sensorimotor gating deficits in multiple system atrophy: Comparison with Parkinson's disease and idiopathic REM sleep behavior disorder
  74. Sleep-spindle detection: crowdsourcing and evaluating performance of experts, non-experts and automated methods
  75. Effect of intermittent aerobic exercise on sleep quality and sleep disturbances in patients with rheumatoid arthritis – design of a randomized controlled trial
  76. Comorbidity and medication in REM sleep behavior disorder: A multicenter case-control study
  77. Sleep Disturbances After Fast-Track Hip and Knee Arthroplasty
  78. Rapid Eye Movement Sleep Behavior Disorder as an Outlier Detection Problem
  79. Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998–2010
  80. The Incidence of Late-Onset Pompe Disease in Subjects with Obstructive Sleep Apnea: A Cross-Sectional Study
  81. Corrigendum to “Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group” [S...
  82. Economic and Health Consequences of COPD Patients and Their Spouses in Denmark—1998–2010
  83. Parkinsonism as an outlier detection problem
  84. Mortality of obesity hypoventilation with and without CPAP Treatment : a controlled national study
  85. Morbidity and mortality in children with obstructive sleep apnea: a controlled national study
  86. Usage of psychotropic medication in obstructive sleep apnea: a controlled national study
  87. EIF3G is associated to narcolepsy
  88. Age-related changes in sleep pattern and sleep structure and the association to cognitive performance: the metropolit 1953 danish male birth cohort
  89. Increased motor activity during rem sleep is linked with dopamine function in idiopathic rem sleep behaviour disorder and Parkinson’s disease
  90. All-cause mortality of sleep apnoea with and without CPAP treatment in male and female patients: A controlled national study
  91. miRNA profiling in plasma from patients with sleep disorders reveals dysregulation of miRNAs in narcolepsy and other central hypersomnias
  92. Reduced sympathetic activity in idiopathic rapid-eye-movement sleep behavior disorder and Parkinson's disease
  93. Design and Synthesis of Organic Molecules for Molecular Electronics
  94. Corrigendum to “Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners” [Sleep Med 13/8 (2012) 1086–1093]
  95. Physical activity maintenance in patients with rheumatoid arthritis: a qualitative study
  96. Activity, Sleep and Cognition After Fast-Track Hip or Knee Arthroplasty
  97. Sleep Transitions in Hypocretin-Deficient Narcolepsy
  98. Morbidities in rapid eye movement sleep behavior disorder
  99. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy
  100. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
  101. Acute Sleep Restriction Reduces Insulin Sensitivity in Adolescent Boys
  102. Detection of a sleep disorder predicting Parkinson's disease
  103. SLEEP phenomena as an early biomarker for Parkinsonism
  104. Automatic SLEEP staging: From young aduslts to elderly patients using multi-class support vector machine
  105. Classification of iRBD and Parkinson's disease patients based on eye movements during sleep
  106. Classification of iRBD and Parkinson's patients using a general data-driven sleep staging model built on EEG
  107. Health, social and economic consequences of hypersomnia: a controlled national study from a national registry evaluating the societal effect on patients and their partners
  108. Morbidity and mortality in children with obstructive sleep apnoea: a controlled national study
  109. Comorbidity and Mortality of Narcolepsy: A Controlled Retro- and Prospective National Study
  110. Increased serum brain-derived neurotrophic factor (BDNF) levels in patients with narcolepsy
  111. OP0102-HPR Sedentary Behaviour in Danish Patients with Rheumatoid Arthritis - What is the Association to Pain, Fatigue, Sleep and Physical Function? A Cross-Sectional Study
  112. Family history of idiopathic REM behavior disorder: A multicenter case-control study
  113. Low-frequency oscillations and vasoreactivity of cortical vessels in obstructive sleep apnea during wakefulness: A near infrared spectroscopy study
  114. Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies
  115. Social consequences of sleep disordered breathing on patients and their partners: a controlled national study
  116. Listening to music for improving sleep in adults with insomnia
  117. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study
  118. The characterization of sleep--wake pattern and its association with melatonin, as a marker of the circadian function of the suprachiasmatic nucleus, in craniopharyngioma patients
  119. Health, Social, and Economic Consequences of Neck Injuries
  120. Dynamics of muscle activation during tonic–clonic seizures
  121. Characteristics of rapid eye movement sleep behavior disorder in narcolepsy
  122. Morbidity prior to a Diagnosis of Sleep-Disordered Breathing: A Controlled National Study
  123. ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
  124. The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
  125. Hypocretin Deficiency Develops During Onset of Human Narcolepsy with Cataplexy
  126. Attenuated Heart Rate Response is Associated with Hypocretin Deficiency in Patients with Narcolepsy
  127. Manipulation of organic polyradicals in a single-molecule transistor
  128. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society
  129. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study
  130. Treatment options for residual insomnia in schizophrenia
  131. Obstructive Sleep Apnea in a Danish Population of Men and Women Aged 60-80 Years with Nocturia
  132. Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus
  133. Health, social, and economic consequences of narcolepsy: A controlled national study evaluating the societal effect on patients and their partners
  134. Predictors of Hypocretin (Orexin) Deficiency in Narcolepsy Without Cataplexy
  135. A New Class of Extended Tetrathiafulvalene Cruciform Molecules for Molecular Electronics with Dithiafulvene-4,5-Dithiolate Anchoring Groups
  136. Automatic detection of REM sleep in subjects without atonia
  137. Evaluation of novel algorithm embedded in a wearable sEMG device for seizure detection
  138. Separation of Parkinson's patients in early and mature stages from control subjects using one EOG channel
  139. Validation of a novel automatic sleep spindle detector with high performance during sleep in middle aged subjects
  140. Sleep disturbances after fast-track hip and knee arthroplasty
  141. The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study
  142. Sleep restriction is not associated with a positive energy balance in adolescent boys
  143. Chronic pain and sleep disorders
  144. Environmental risk factors for REM sleep behavior disorder: A multicenter case-control study
  145. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency
  146. A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study
  147. Attenuated heart rate response in REM sleep behavior disorder and Parkinson's disease
  148. Health, Social And Economical Consequences Of Chronic Obstructive Pulmonary Disease (COPD): A Controlled National Study
  149. Cluster headache and sleep, is there a connection? A review
  150. Sleep disturbances in critically ill patients in ICU: how much do we know?
  151. Corrigendum to “Cost of disorders of the brain in Europe 2010” [Eur. Neuropsychopharmacol. 21 (2011) 718–779]
  152. Molecular Junctions Based on SAMs of Cruciform Oligo(phenylene ethynylene)s
  153. A Computerized Algorithm for Arousal Detection in Healthy Adults and Patients With Parkinson Disease
  154. The socioeconomic consequences of multiple sclerosis: A controlled national study
  155. Standard procedures for adults in accredited sleep medicine centres in Europe
  156. Insomnia in central neurologic diseases – Occurrence and management
  157. Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
  158. Cost of disorders of the brain in Europe 2010
  159. Erratum: Common variants in P2RY11 are associated with narcolepsy
  160. Sleep Disorders in Neurodegenerative Disorders and Stroke
  161. M-N-126 RETROSPECTIVE EVALUATION OF PREGNANCIES IN EUROPEAN NARCOLEPTICWOMEN
  162. The size and burden of mental disorders and other disorders of the brain in Europe 2010
  163. Automatic REM sleep detection associated with idiopathic rem sleep Behavior Disorder
  164. Detection of arousals in Parkinson's disease patients
  165. Changes in cerebral glucose metabolism in early symptomatic frontotemporal dementia linked to chromosome 3 (FTD-3)
  166. Clinical presentation and mutations in Danish patients with Wilson disease
  167. Erratum: Corrigendum: Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy
  168. The health-related, social, and economic consequences of parkinsonism: a controlled national study
  169. The social and economic consequences of epilepsy: A controlled national study
  170. Health, social and economical consequences of sleep-disordered breathing: a controlled national study
  171. Synthesis of Oligo(phenyleneethynylene)s with Vertically Disposed Tetrathiafulvalene Units
  172. Common variants in P2RY11 are associated with narcolepsy
  173. P9-1 Multi-modal REM behaviour disorder detection associated with neurodegenerative diseases
  174. P22-21 PPI of the acoustic startle response is associated with visual processing and executive function in idiopathic RBD and Parkinson's disease
  175. P9-8 Validation of manual and automatic sleep scoring in normals and patients with neurodegenerative disorders
  176. P9-10 REM sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency
  177. P9-11 Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population
  178. Intravenous Immunoglobulin Treatment and Screening for Hypocretin Neuron-Specific Autoantibodies in Recent Onset Childhood Narcolepsy with Cataplexy
  179. Sleep Disorders in Neurodegenerative Disorders and Stroke
  180. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy
  181. REM Behaviour Disorder detection associated with neurodegenerative diseases
  182. Automatic Sleep Scoring in Normals and in Individuals With Neurodegenerative Disorders According to New International Sleep Scoring Criteria
  183. The socio-economical burden of hypersomnia
  184. Anal sphincter EMG in the diagnosis of parkinsonian syndromes
  185. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency
  186. Sodium oxybate is an effective and safe treatment for narcolepsy
  187. Quality of life, co-morbidity and obstructive sleep apnoea
  188. Sleep disordered breathing following spinal cord injury
  189. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing
  190. Language function following subdural grid-directed temporal lobectomy
  191. Outcome of resective surgery for intractable partial epilepsy guided by subdural electrode arrays
  192. Effect of barbiturate on epileptiform activity: comparison between intravenous and oral administration
  193. Nocturia and associated morbidity in a Danish population of men and women aged 60-80 years
  194. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis
  195. Medico-legal implications of sleep apnoea syndrome: Driving license regulations in Europe
  196. Rapid Eye Movement Sleep Disturbances in Huntington Disease
  197. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea–hypopnoea syndrome
  198. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke)
  199. Pathophysiological Aspects of Nocturia in a Danish Population of Men and Women Age 60 to 80 Years
  200. Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia
  201. Antibodies in narcolepsy???cataplexy patient serum bind to rat hypocretin neurons
  202. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years
  203. Validity and Reliability of a Questionnaire for Evaluating Nocturia, Nocturnal Enuresis and Sleep-Interruptions in an Elderly Population
  204. Spontaneous Epileptic Rats Show Changes in Sleep Architecture and Hypothalamic Pathology
  205. Measurement of cortical and hippocampal epileptiform activity in freely moving rats by means of implantable radiotelemetry
  206. Motor evoked potentials from the striated urethral sphincter and puborectal muscle: reproducibility of latencies
  207. Motor evoked potentials from the striated urethral sphincter and puborectal muscle: Normative values
  208. Motor evoked potentials from the striated urethral sphincter: A comparison of concentric needle and surface electrodes
  209. Sleep and nocturia
  210. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society
  211. Sleep and headache
  212. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents
  213. The standardisation of terminology in nocturia: Report from the standardisation sub-committee of the International Continence Society
  214. The effect of oral desmopressin (Minirin®) on sleep in male and female patients with nocturia
  215. Short-term reproducibility of cystometry and pressure-flow micturition studies in healthy women
  216. Motor evoked potentials from the external anal sphincter in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p
  217. Nocturia in women
  218. Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p
  219. A computer-based information system for epilepsy and electroencephalography
  220. Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study
  221. A prospective study of 39 patients with whiplash injury
  222. P420 Repetitive magnetic stimulations of the rat
  223. Snoring and atherosclerotic manifestations in a 70-year-old population
  224. Repetitive transcranial magnetic stimulations of the rat effect of acute and chronic stimulations on pentylenetetrazole-induced clonic seizures
  225. Snoring and Headache: An Important Association-Reply
  226. Risk of Ischemic Heart Disease in Self-reported Snorers
  227. Snoring, Family History, and Genetic Markers in Men
  228. Repetitive magnetic stimulation and motor evoked potentials
  229. Headache and Cognitive Dysfunctions in Snorers
  230. EEG changes following repetitive transcranial magnetic stimulation in patients with temporal lobe epilepsy
  231. Transcranial magnetic stimulation. Its role in the evaluation of patients with partial epilepsy
  232. Speech localization using repetitive transcranial magnetic stimulation
  233. Self-Assessed Cognitive Function in Snorers and Sleep Apneics
  234. Snoring and Risk of Stroke and Ischaemic Heart Disease in a 70 Year Old Population. A 6-Year Follow-up Study
  235. Self-Reported Sleep Disturbances and Daytime Complaints in Women with Fibromyalgia and Rheumatoid Arthritis
  236. Snoring, sympathetic activity and cardiovascular risk factors in a 70 year old population
  237. Speech localization using transcranial repetitive magnetic stimulation. A new diagnostic tool in the evaluation of patients with epilepsy
  238. Repetitive magnetic stimulation of the cortex and a peripheral nerve
  239. Snoring, Sleep Apnoea and Cardiovascular Risk Factors: The MONICA II Study
  240. Alpha Intrusion in Fibromyalgia
  241. PATHOLOGY OF SKELETAL MUSCLE IN FIBROMYALGIA: A HISTO-IMMUNO-CHEMICAL AND ULTRASTRUCTURAL STUDY
  242. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60
  243. Cardiovascular risk factors in snorers. A cross-sectional study of 3,323 men aged 54 to 74 years: the Copenhagen Male Study.
  244. Compound motor action potentials generated by repetitive magnetic stimulation
  245. Compound Motor Action Potentials Generated By Repetitive Magnetic Stimulation
  246. An epidemiological study of REM latency and psychiatric disorders
  247. Zopiclone in the Treatment of Sleep Abnormalities in Fibromyalgia
  248. Blood Pressure, Catecholamines, and Pancreatic Polypeptide in Obstructive Sleep Apnea With and Without Nasal Continuous Positive Airway Pressure (nCPAP) Treatment
  249. Intracranial Pressure and Obstructive Sleep Apnea
  250. White lead exposure among Danish police officers employed in fingerprint detection.
  251. Adaptive Segmentation Of EEG Signals
  252. Sleep Disorders in Neurologic Disease